A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation

The traditional xenograft subcutaneous pancreatic cancer model is notorious for its low incidence of tumor formation, inconsistent results for the chemotherapeutic effects of drug molecules of interest, and a poor predictive capability for the clinical efficacy of novel drugs. These drawbacks are at...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qingyi, Wang, Xiaohui, Zhang, Xing, Han, Huifang, Han, Baosan, Xu, Jianzhong, Tang, Kanglai, Fu, Zhiren, Yin, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607421/
https://www.ncbi.nlm.nih.gov/pubmed/23658483
http://dx.doi.org/10.2147/IJN.S42464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607421/
https://www.ncbi.nlm.nih.gov/pubmed/23658483
http://dx.doi.org/10.2147/IJN.S42464

Ejemplares similares